Efficacy of Linaclotide to Senna for CIC

Status Terminated

Clinical Trial Summary

In this prospective, randomized, double blind study, the aim is to determine the efficacy of Linaclotide in relation to Senna in relieving the symptoms of chronic idiopathic constipation (CIC). Patients with CIC, (age 18 - 70) will be enrolled in the study and randomized to Senna or Linaclotide. Patients will be asked to complete questionnaires during the study and will be followed for 12 weeks. Main outcomes include number of daily bowel movements and measures from surveys regarding bowel habits, relief, and satisfaction.

Clinical Trial Description

In this prospective, randomized, double blind study, the aim is to determine the efficacy of Linaclotide in relation to Senna in relieving the symptoms of chronic idiopathic constipation (CIC). Our hypothesis is that Senna is not inferior to Linaclotide in the treatment of CIC. Seventy patients aged 18-70 diagnosed with CIC and seen by a gastroenterologist affiliated with TriHealth or a patient of the Faculty Medical Center clinic will be included in the study. After enrollment, subjects will be randomized to receive either Linaclotide or Senna over a 12-week period after a 1 week wash-out period. During th study period, subjects will complete a log to record the number of daily bowel movements. The subjects will also complete 3 validated surveys on a weekly basis: Subject's Global Assessment SGA of Relief, Subject's Global Assessment SGA of Bowel Habit, and SGA of Satisfaction with their Bowel Habit. A research nurse will meet with subjects at the beginning of the study and then at 3 monthly visits to administer the study medication and distribute the surveys. The main outcomes measures are change in # of bowel movements and SGA survey scores. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02239510
Study type	Interventional
Source	TriHealth Inc.
Contact
Status	Terminated
Phase	N/A
Start date	September 2014
Completion date	June 2016

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02361749` - Botulinum Toxin Injection Versus Anal Myectomy in Management of Idiopathic Constipation	Phase 4
Completed	`NCT01895543` - Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation	Phase 3
Completed	`NCT01460225` - Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation	Phase 4
Completed	`NCT02291679` - Trial of Linaclotide in Patients With Chronic Idiopathic Constipation	Phase 3
Completed	`NCT01993875` - Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation	Phase 3
Completed	`NCT01989234` - A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation	Phase 2
Completed	`NCT01674530` - Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation	Phase 3
Completed	`NCT01429987` - The Plecanatide Chronic Idiopathic Constipation (CIC) Study	Phase 2/Phase 3
Completed	`NCT01982240` - 12-Week Study of Plecanatide for CIC (The CIC3 Study)	Phase 3
Completed	`NCT02590432` - An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation	Phase 4
Completed	`NCT02481947` - A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults	Phase 3
Completed	`NCT01372423` - Evaluation of Clinical Equivalence Between Two Lubiprostone Products	Phase 3
Completed	`NCT03054506` - The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation	N/A
Recruiting	`NCT04804267` - Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation	Phase 3
Completed	`NCT03879239` - Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation	N/A
Completed	`NCT01053962` - SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation	Phase 2
Completed	`NCT03097861` - Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo	Phase 3
Completed	`NCT03551873` - A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®
Completed	`NCT02819310` - An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults	Phase 3
Completed	`NCT02819297` - BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults	Phase 3